News Image

Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy

Provided By GlobeNewswire

Last update: Sep 5, 2025

EGRIFTA WR™ offers convenience of weekly reconstitution and reduced daily injection volume, compared to EGRIFTA SV®

Specialty pharmacies are now ordering EGRIFTA WR™ to fill prescriptions

Read more at globenewswire.com

THERATECHNOLOGIES INC

NASDAQ:THTX (9/11/2025, 8:17:34 PM)

After market: 3.24 -0.04 (-1.22%)

3.28

+0.01 (+0.31%)



Find more stocks in the Stock Screener

Follow ChartMill for more